Significance of detectable HCV RNA below the limit of quantification in patients treated with DAAs using standard and ultrasensitive protocols-Reference-Cited by-同舟云学术

Significance of detectable HCV RNA below the limit of quantification in patients treated with DAAs using standard and ultrasensitive protocols

Published:2018-04-26 Issue:7 Volume:90 Page:1264-1271
ISSN:0146-6615
Container-title:Journal of Medical Virology
language:en
Short-container-title:J Med Virol

Author:

Visco-Comandini Ubaldo¹^ORCID,Lapa Daniele²,Lionetti Raffaella¹,Taibi Chiara¹,Loiacono Laura¹,Montalbano Marzia¹,Capobianchi Maria R.²,D'Offizi Gianpiero¹,Garbuglia Anna R.²

Affiliation:

1. Infectious Disease-Hepatology Unit; POIT Department, National Institute for Infectious Diseases, INMI Lazzaro Spallanzani IRCCS; Rome Italy

2. Virology Unit; National Institute for Infectious Diseases, INMI Lazzaro Spallanzani IRCCS; Rome Italy

Funder

Ministero della Salute, Ricerca Corrente, Linea Epatiti (Italian Ministry of Health)

Publisher

Wiley

Subject

Infectious Diseases,Virology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/jmv.25084/fullpdf

Reference21 articles.

1. Optimal treatment with telaprevir for chronic HCV infection;Jesudian;Liver Int,2013

2. Optimal treatment with boceprevir for chronic HCV infection;Maasoumy;Liver Int,2013

3. Ultrasensitive HCV RNA quantification in antiviral triple therapy: new insight on viral clearance dynamics and treatment outcome predictors;Garbuglia;PLoS ONE,2016

4. EASL recommendations on treatment of Hepatitis C;J Hepatol,2017

5. New hepatitis C therapies: the toolbox, strategies, and challenges;Pawlotsky;Gastroenterology,2014

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy, safety and feasibility of treatment of chronic HCV infection with directly acting agents in hematopoietic stem cell transplant recipients – Study of infectious diseases working party of EBMT;Journal of Infection;2022-01

2. Clinical Relevance of Torque Teno Virus (TTV) in HIV/HCV Coinfected and HCV Monoinfected Patients Treated with Direct-Acting Antiviral Therapy;Journal of Clinical Medicine;2021-05-13

3. Ribavirin facilitates early viral kinetics in chronic hepatitis C patients receiving daclatasvir/asunaprevir;Journal of Gastroenterology and Hepatology;2019-08-15